| 注册
首页|期刊导航|中国全科医学|基于两种定价模型分析下的基本药物定价模型研究

基于两种定价模型分析下的基本药物定价模型研究

张环宇 韦冠 邵蓉

中国全科医学2013,Vol.16Issue(4):425-426,2.
中国全科医学2013,Vol.16Issue(4):425-426,2.DOI:10.3969/j.issn.1007-9572.2013.02.022

基于两种定价模型分析下的基本药物定价模型研究

Comparison of Three Pricing Methods and Two Pricing Models foREssential Drugs

张环宇 1韦冠 1邵蓉1

作者信息

  • 1. 211198,江苏省南京市,中国药科大学国际医药商学院
  • 折叠

摘要

Abstract

Objective To improve the pricing system of essential drug. Methods The advantages and disadvantages of three pricing methods for essential drugs, namely, cost - driven pricing, customer - driven pricing, and competition - driven pricing, were analyzed and compared. A cost - driven pricing model and mixed model were built on the above - mentioned pricing methods. The strengths and weaknesses of the two models were compared. Results The cost - driven pricing is favorable to the enterprises, because information of cost is easily attainable, and the price is assured to be above the cost. But it lacks considerations of the market features such as demand and competition. The customer - driven pricing is customer - friendly, because it's made according to the market demand. But the customer's demand is hard to identify and the final price may not be accepted by the enterprises. The competition - driven model helps the enterprise to be advantageous to their competitors regarding price and still gain profit. But it's hard and costly to apply. Conclusion None of the three pricing methods for essential drugs are independently applicable. Productivity growth rate, retail price index, market supply and demand should be considered apart from cost to establish a reasonable and objective pricing system.

关键词

基本药物/定价/模型研究

Key words

Essential Drugs/ Pricing/ Model analysis

分类

医药卫生

引用本文复制引用

张环宇,韦冠,邵蓉..基于两种定价模型分析下的基本药物定价模型研究[J].中国全科医学,2013,16(4):425-426,2.

中国全科医学

OA北大核心CSCDCSTPCD

1007-9572

访问量0
|
下载量0
段落导航相关论文